@article{b02ee119a2c344ae97d5858ba632825d,
title = "Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis",
author = "Rosenbaum, {Cara A.} and Umut {\"O}zbek and Larysa Sanchez and Jonathan Lagdameo and Alex Abrahams and Hani Hassoun and Oscar Lahoud and Ruben Niesvizky and Landau, {Heather J.} and Keren Osman",
note = "Funding Information: Acknowledgments: Suzanne Lentzsch was instrumental in helping with the concept for this trial and the preliminary design. Editorial support was provided by Hannah Rice. Funding Information: This study was supported in part by a grant from Takeda Pharmaceutical and by Memorial Sloan-Kettering Cancer Center Core Grant (P30 CA008748).",
year = "2022",
month = sep,
day = "27",
doi = "10.1182/bloodadvances.2022007826",
language = "English",
volume = "6",
pages = "5436--5439",
journal = "Blood advances",
issn = "2473-9529",
publisher = "Elsevier BV",
number = "18",
}